SPOTLIGHT -
Dr. Llanos on the Role of Social and Biological Determinants on Cancer Risk
Adana A.M. Llanos, PhD, MPH, discusses the role of social and biological determinants on cancer risk.
Read More
Dr. Llanos on Genetic Disparities in Cancer Care
Adana A.M. Llanos, PhD, MPH, discusses disparities in genetic research in cancer care.
Dr. Llanos on Recognizing Social Determinants of Disparities in Cancer Care
Adana A.M. Llanos, PhD, MPH, discusses how to recognize social determinants of disparities in cancer care.
PD-1 Inhibitor Combinations, Alternative Therapeutic Approaches Are Moving the Needle in NSCLC
Better Understanding of Biomarkers Can Inform Immunotherapy Treatment in SCLC
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
